Altamira Therapeutics Ltd. (CYTO) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-05-15
3:25 pm
Sale
2025-03-3113GALTAMIRA THERAPEUTICS LTD SHS
CYTOF
Armistice Capital, LLC473,870
9.990%
-4,677decrease
(-0.98%)
Filing
History
2025-05-06
06:39 am
Purchase
2025-04-3013DALTAMIRA THERAPEUTICS LTD SHS
CYTOF
Thomas Meyer1,079,843
18.900%
1,057,546increase
(+4743.00%)
Filing
History
2025-02-14
5:41 pm
Purchase
2024-12-3113GALTAMIRA THERAPEUTICS LTD SHS
CYTOF
Armistice Capital, LLC478,547
9.990%
70,437increase
(+17.26%)
Filing
History
2024-11-14
3:27 pm
Purchase
2024-09-3013GALTAMIRA THERAPEUTICS LTD SHS
CYTOF
Armistice Capital, LLC408,110
9.990%
408,110increase
(New Position)
Filing
History
2024-03-13
11:03 am
Purchase
2024-03-1313DALTAMIRA THERAPEUTICS LTD SHS
CYTOF
Thomas Meyer22,297
1.200%
17,867increase
(+403.32%)
Filing
History
2023-04-27
4:30 pm
Purchase
2023-04-1713DALTAMIRA THERAPEUTICS LTD SHS
CYTO
Thomas Meyer4,430
1.300%
225increase
(+5.35%)
Filing
History
2023-01-18
4:30 pm
Purchase
2023-01-0313DALTAMIRA THERAPEUTICS LTD SHS
CYTO
Thomas Meyer4,205
6.300%
12increase
(+0.29%)
Filing
History
2022-09-13
08:00 am
Purchase
2022-09-0913DALTAMIRA THERAPEUTICS LTD SHS
CYTO
Thomas Meyer4,193
8.000%
1,284increase
(+44.14%)
Filing
History
2022-05-13
08:32 am
Purchase
2022-05-1213DALTAMIRA THERAPEUTICS LTD SHS
CYTO
Thomas Meyer2,909
7.400%
866increase
(+42.39%)
Filing
History